News

Opinion - The FDA must crack down on dangerous knockoff weight-loss drugs
Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...
The FDA must crack down on dangerous knockoff weight-loss drugs
Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...
Lawmakers Press FDA to Target Knockoff Weight-Loss Drugs
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.